Company: CERO
Filing Date: 2025-11-19
Form Type: 10-Q
Source: 0001213900-25-112619
Chunk: 6

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-11-19
Form: 10-Q
Item: Item 1
Chunk 6
---
,429  
    $1,287,315  
     -  
    $-  
     7  
    $2,292  
     9,800  
    $7,408,866  
     1,496,398  
    $150  
    $73,055,709  
    $-  
    $(86,297,494) 
    $(4,543,162)

3

    Convertible
Preferred Stock  
    Series A  
    Additional  
    Stock 

    Total 

    Series A  
    Series B  
    Series C  
    Series D  
     Common Stock  
    Paid-in  
    Subscriptions 
     
    Accumulated  
    Stockholders’ 

    Shares  
    Amount  
    Shares  
    Amount  
    Shares  
    Amount  
    Shares  
    Amount  
    Shares  
    Amount  
    Capital  
    Receivable 
     
    Deficit  
    Deficit 
  
    Balance at February
    14, 2024 (Successor) 
     10,089  
    $8,937,852  
     -  
    $-  
     -  
    $-  
     -  
    $     -  
     7,266  
    $1  
    $53,899,885  
    $(2,000,000)
     
    $(63,185,641) 
    $(2,347,903)
  
    Issuance of Series B shares
sold to investors for stock subscription receivable 
     -  
     -  
     626  
     500,000  
     -  
     -  
     -  
     -  
     -  
     -  
     -  
     (500,000)
     
     -  
     - 
  
    Stock-based compensation 
     -  
     -  
     -  
     -  
     -  
     -  
     -  
     -  
     -  
     -  
     96,289  
     - 
     
     -